Emcure Pharmaceuticals has acquired the remaining 12.05% stake in Gennova Biopharmaceuticals, making the Maharashtra based biotechnology company a wholly owned subsidiary. The move is aimed at strengthening Emcure's presence in the fast-growing biologics and biosimilars segment while simplifying the company's ownership structure under its One
Revenue from operations at Rs 1,963 Cr, up 17.7% YoY EBITDA margins at 18.4% with EBITDA up 23.2% YoY PAT at 156Cr, up 30.3% YoY Domestic business sales at 888 Cr, up 12.0% YoY International business sales at 1,075 Cr, up 23.0% YoY Emcure Pharmaceuticals
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
